Keyphrases
Academic Hospital
8%
Adipose-derived Mesenchymal Stem Cells (ADMSCs)
24%
Amniotic Mesenchymal Stem Cells
6%
Bacterial Index
7%
Blood Vein
6%
Chemoprophylactic
6%
Co-infection
7%
Conditioned Medium
6%
Coping Strategies
6%
COVID-19
12%
Cutaneous Wound Healing
6%
Diffuse Lepromatous Leprosy
12%
Disability
25%
Double-blind Randomized Clinical Trial
6%
Endemic Countries
7%
Erythema Nodosum Leprosum
15%
Gauze Dressing
7%
Grade 2 Disability
10%
Gresik
12%
Growth Factors
15%
Healing
10%
Health Sciences
6%
Hepar
6%
Herpes Zoster
6%
Ig M
6%
Indonesia
41%
Leprosy
100%
Leprosy Patients
42%
Leprosy Reactions
12%
Leprosy Services
6%
Lycopersicon Esculentum
6%
M. Lepromatosis
9%
Mesenchymal Stem Cell-conditioned Medium
18%
Multicenter Retrospective Study
6%
Mycobacterium Leprae
19%
Mycobacterium Lepromatosis
7%
Outpatient Clinic
8%
Phenolic Glycolipids
7%
Plantar Ulcer
18%
Prednisolone
6%
Randomized Controlled Trial
19%
Referral Center
6%
Resveratrol
6%
Risk Factors
18%
Sexual Health
6%
Single Center
6%
Skin Health
6%
Stem Cell Metabolites
6%
Surabaya
25%
Ulcer
9%
Medicine and Dentistry
Adipose Tissue
6%
Alpha Tocopherol
6%
Amnion
12%
Ascorbic Acid
6%
Cohort Effect
12%
COVID-19
18%
Cross Sectional Study
12%
Dermatology
10%
Disease Burden
6%
Diseases
28%
Disseminated Herpes Zoster
6%
Erythema Nodosum Leprosum
31%
Framycetin
6%
Histopathology
8%
Immunity
7%
Immunoglobulin M Antibody
6%
Infection
16%
Lagophthalmos
6%
Lepromatous Leprosy
12%
Lopinavir/Ritonavir
6%
Medical Record
12%
Mesenchymal Stem Cell
18%
Metabolite
7%
Methotrexate
6%
Mixed Infection
8%
Mycobacteria
8%
Mycobacterium leprae
16%
Neuropathy
6%
Outpatient
16%
Patient Referral
6%
Pediatrics
9%
Peroneus Nerve Paralysis
6%
Personal Experience
6%
Physical Activity
6%
Placenta
6%
Plantar Ulcer
24%
Polypharmacy
10%
Prednisolone
6%
Prevalence
11%
Primary Health Care
6%
Public Health
17%
Quality of Life
14%
Randomized Clinical Trial
6%
Randomized Controlled Trial
19%
Retrospective Study
28%
Secondary Data
7%
Stem Cell
6%
Ulcer
21%
Urticaria
6%
Venereology
10%